Euroapi: stock falls on broker downgrade

(CercleFinance.com) - On Thursday Deutsche Bank downgraded its rating on Euroapi shares from "buy" to "hold", reducing its corresponding target price from 22 euros to 17 euros.


In a reaction note, the analyst believes that the "surprise" warning made by the manufacturer of active ingredients for the pharmaceutical industry implies a downward revision of around 13% of the consensus forecasts established for 2022.

Deutsche Bank adds that it expects market estimates for 2023 to be reduced as well.

After excellent H1 earnings (the first since its spin-off from Sanofi in May 2022), yesterday's news comes as a premature blow for DB's investment thesis, it said.


Copyright (c) 2022 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.